User banner image
User avatar
  • Editorial Team

Posts

New York sketches out $500M plan to build a biotech hub

New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The latest...

REGENERON FORMS CONSORTIUM OF LEADING LIFE SCIENCES COMPANIES TO ACCELERATE LARGEST WIDELY-AVAILABLE ‘BIG DATA’ HUMAN SEQUENCING RESOURCE WITH UK BIOBANK

By end of 2019, Regeneron plans to sequence the exomes of all 500,000 people within the UK Biobank resource, all with associated health records, creating...

Trials for Alzheimer’s Drug Halted After Poor Results

Pfizer Inc. on  Saturday said it would stop trying to discover new drugs for Alzheimer’s disease and Parkinson’s disease, abandoning costly but futile efforts to find...

SBIR/STTR WORKSHOP – NIH FOCUSED

UPCOMING: SBIR/STTR WORKSHOP – NIH FOCUSED Wednesday January 17 & Thursday January 18, 2018 (1.5 days)  Long Island High Technology Incubator Hosted by the Center...

2018 CRC Guide Now out!

The CRC’s Guide to Coordinating Clinical Research, Third Edition The CRC’s Guide to Coordinating Clinical Research, 3rd edition, is the most comprehensive, easy-to-read training guide...

Q Therapeutics and REPROCELL Partnering on Stem Cell-based Therapies for ALS

Q Therapeutics of the United States and REPROCELL of Japan are teaming up to develop stem cell-based therapies for central nervous system diseases such as ALS and transverse myelitis,...

Neurologist Talks About Diagnosing ALS

Neurologist Dr. Elijah Stommel explains that he sees two newly diagnosed ALS patients each week and that each case is unique. In Andy’s case, the...

BrainStorm Cell Therapeutics to Present at the 10th Annual Biotech Showcase

HACKENSACK, N.J. and PETACH TIKVAH, Israel, Dec. 20, 2017 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that Chaim...

IQVIA: new article out “Heralding the Era of Human Data Science”

IQVIA, the recently formed merger of IMS Health and Quintiles, just announced publication of ““Heralding the Era of Human Data Science”.   “Human Data Science is...

Why We Should Talk to Patients Who Drop Out of Clinical Trials

Dec 13, 2017 By Sandy Chase Applied Clinical Trials Like so many of my colleagues in the world of clinical patient recruitment and retention, I spend...